Regulus Therapeutics
RGLS
#6950
Rank
C$0.77 B
Marketcap
C$11.22
Share price
0.00%
Change (1 day)
418.67%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: C$0.77 Billion

As of December 2025 Regulus Therapeutics has a market cap of C$0.77 Billion. This makes Regulus Therapeutics the world's 6950th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.77 B436.45%
2024C$0.14 B321.6%
2023C$34.33 M9.67%
2022C$31.3 M-46.58%
2021C$58.59 M-46.39%
2020C$0.10 B347.42%
2019C$24.43 M118.57%
2018C$11.17 M-91.78%
2017C$0.13 B-15.06%
2016C$0.16 B-74.88%
2015C$0.63 B-30.07%
2014C$0.91 B177.15%
2013C$0.32 B46.44%
2012C$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
C$135.41 B 17,339.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$159.15 B 20,396.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$34.58 B 4,353.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$389.29 B 50,034.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
C$71.02 B 9,047.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.20 B-73.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$151.73 B 19,441.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.09 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA